Compare OGN & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | SHLS |
|---|---|---|
| Founded | 1923 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | 2020 |
| Metric | OGN | SHLS |
|---|---|---|
| Price | $13.38 | $12.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $11.40 | $9.07 |
| AVG Volume (30 Days) | 5.0M | ★ 5.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ 42.86 |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | $475,331,000.00 |
| Revenue This Year | $0.45 | $26.24 |
| Revenue Next Year | $1.67 | $11.52 |
| P/E Ratio | ★ $24.28 | $41.63 |
| Revenue Growth | N/A | ★ 19.07 |
| 52 Week Low | $5.69 | $3.99 |
| 52 Week High | $13.48 | $12.50 |
| Indicator | OGN | SHLS |
|---|---|---|
| Relative Strength Index (RSI) | 74.68 | 74.87 |
| Support Level | $10.05 | $7.40 |
| Resistance Level | $13.46 | N/A |
| Average True Range (ATR) | 0.05 | 0.89 |
| MACD | -0.22 | 0.28 |
| Stochastic Oscillator | 47.50 | 81.28 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.